Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  furosemide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 37 for your search:
Start Over
Phase III Study with CACP vs ADR/CTX/CACP & Phase II Study with VM-26 for Disseminated Transitional Cell Urinary Tract Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1878
Phase II Chemotherapy with L-PAM in Patients with Metastatic Colorectal Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8373
Phase I/II Pilot Combination Chemotherapy with Intraperitoneal L-PAM/CACP in Patients with Stage III/IV Ovarian Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PD-882, EST-P-D882
Phase I/II Intrapleural Combination Chemotherapy with CACP/ARA-C in Patients with Malignant Involvement of the Pleura
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCSD-84124, NCI-V85-0023
Phase I/II Master Protocol Pilot Evaluation of Single-Agent or Combination Chemotherapy for Stage III Myeloma --- High-Dose L-PAM/CTX (Summary Last Modified 01/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8512, CALGB-8512
Phase I/II High-Dose Combination Chemotherapy with CTX/ARA-C/AMSA/CACP plus TBI and Autologous Bone Marrow Therapy for Refractory Diffuse Aggressive Lymphomas and Hodgkin's Disease
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-215, NCI-MB-187, NCI-T84-0257N
Phase II Chemotherapy with VBL/CACP/BLEO for Metastatic Nonseminomatous Testicular Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-048-130, WCCC-CO-7881
Phase II Chemotherapy with CACP/ADR in Patients with Advanced Prostatic Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D78-048-141, WCCC-CO-7883
Phase II Sequential Chemotherapy with CTX Followed by High-Dose L-Pam for Refractory Acute Leukemia, Lymphoma, and Selected Solid Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: NCI-D79-017-183
Phase II Chemotherapy with CACP for Refractory Sarcomas and Gastrointestinal Neoplasms
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-21377
Phase II Pilot Study of CACP/BLEO/Standard-Dose MTX with Leucovorin Rescue for Advanced or Refractory Squamous Cell Carcinoma of the Uterine Cervix
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PA-881
Phase II Chemotherapy with L-PAM for Refractory Carcinoma of the Breast, Small Cell Lung Carcinoma, and Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: NCI-D80-018-135, DFCI-79047
Phase II Chemotherapy with MITO/VP-16/CACP/HMM for Advanced Lung Cancer Refractory to Standard Therapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D80-055-200
Phase II High-Dose L-PAM and Autologous Bone Marrow Reinfusion for Advanced Small Cell Lung Cancer and Head and Neck Cancer (Stage III/IV)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-045-549
Phase II Marrow Ablation and Autologous Bone Marrow Therapy with and without Monoclonal Antibody Treatment of Marrow in Patients with ANLL in First Remission
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FHCRC-132, NCI-V83-0102
Phase II Chemotherapy with CACP in Patients with Gastric Carcinoma Resistant to Standard Chemotherapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: EORTC-40793
Start Over